Westside Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$42.9K	Hold	760	–	–	0.01%	615
2025 Q4	$45.2K	Hold	760	–	–	0.01%	572
2025 Q3	$41.2K	Sell	760 -400	-34%	-$22.9K	0.01%	610
2025 Q2	$63.8K	Hold	1,160	–	–	0.01%	419
2025 Q1	$82K	Sell	1,160 -150	-11%	-$10.1K	0.02%	336
2024 Q4	$86.1K	Hold	1,310	–	–	0.02%	325
2024 Q3	$92.1K	Buy	1,310 +100	+8%	+$8.36K	0.02%	322
2024 Q2	$99.6K	Hold	1,210	–	–	0.02%	308
2024 Q1	$106K	Hold	1,210	–	–	0.03%	287
2023 Q4	$117K	Hold	1,210	–	–	0.03%	261
2023 Q3	$107K	Hold	1,210	–	–	0.03%	265
2023 Q2	$105K	Sell	1,210 -600	-33%	-$56.5K	0.03%	267
2023 Q1	$176K	Sell	1,810 -400	-18%	-$41.5K	0.05%	220
2022 Q4	$228	Sell	2,210 -160	-7%	-$15K	﹤0.01%	314
2022 Q3	$6.97K	Sell	2,370 -1,550	-40%	-$138K	0.02%	213
2022 Q2	$6.66K	Hold	3,920	–	–	0.02%	207
2022 Q1	$6.64K	Hold	3,920	–	–	0.01%	208
2021 Q4	$6.51K	Sell	3,920 -800	-17%	-$66K	0.01%	200
2021 Q3	$6.53K	Buy	4,720 +200	+4%	+$15.8K	0.02%	202
2021 Q2	$7.04K	Buy	4,520 +650	+17%	+$51.5K	0.02%	194
2021 Q1	$6.33K	Buy	3,870 +3,510	+975%	+$287K	0.02%	189
2020 Q4	$31	Buy	+360	New	+$28.5K	﹤0.01%	382